IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
516.60
+15.03 (3.00%)
May 27, 2025, 3:35 PM - Market open
IDEXX Laboratories Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for IDEXX Laboratories stock ranges from a low of $500 to a high of $580. The average analyst price target of $536 forecasts a 3.76% increase in the stock price over the next year.
Price Target: $536.00 (+3.76%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 2 | 2 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $460 → $510 | Hold | Maintains | $460 → $510 | -1.28% | May 19, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $548 → $558 | Buy | Maintains | $548 → $558 | +8.01% | May 5, 2025 |
Stifel | Stifel | Hold Maintains $450 → $420 | Hold | Maintains | $450 → $420 | -18.70% | Apr 14, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $435 → $510 | Hold | Maintains | $435 → $510 | -1.28% | Feb 10, 2025 |
Barclays | Barclays | Buy Maintains $481 → $520 | Buy | Maintains | $481 → $520 | +0.66% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
4.22B
from 3.90B
Increased by 8.17%
Revenue Next Year
4.54B
from 4.22B
Increased by 7.61%
EPS This Year
12.38
from 10.67
Increased by 16.04%
EPS Next Year
13.89
from 12.38
Increased by 12.21%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.4B | 4.7B | 5.1B | ||
Avg | 4.2B | 4.5B | 4.9B | ||
Low | 4.0B | 4.3B | 4.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.3% | 12.1% | 12.4% | ||
Avg | 8.2% | 7.6% | 8.4% | ||
Low | 3.3% | 2.3% | 1.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.93 | 14.46 | 16.65 | ||
Avg | 12.38 | 13.89 | 15.61 | ||
Low | 11.62 | 12.92 | 13.98 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.1% | 16.8% | 19.9% | ||
Avg | 16.0% | 12.2% | 12.4% | ||
Low | 8.9% | 4.3% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.